a Institute Gustave Roussy, Villejuif, France; MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA; Roswell Park Cancer… Click to show full abstract
a Institute Gustave Roussy, Villejuif, France; MD Anderson Cancer Center, University of Texas, Houston, TX, USA; Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA; Roswell Park Cancer Institute, Buffalo, NY, USA; e Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA; f Stanford Cancer Institute, Stanford, CA, USA; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Vanderbilt University Medical Center, Nashville, TN, USA; i Fondazione Istituto Nazionale Tumori, Milan, Italy; j Fox Chase Cancer Center, Philadelphia, PA, USA; Hospital Universitario 12 De Octubre, Madrid, Spain; Westmead Hospital, Westmead, NSW, Australia; Aarhus University Hospital, Aarhus, Denmark; Comprehensive Cancer Center, Helsinki University Central Hospital Cancer Center, Helsinki, Finland; o South West Wales Cancer Institute and Swansea University College of Medicine, Swansea, UK; University Hospital Essen of University of Duisburg-Essen, Essen, Germany; Chiba Cancer Center, Chiba, Japan; Bristol-Myers Squibb, Princeton, NJ, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA
               
Click one of the above tabs to view related content.